Novartis announces lift of partial clinical trial hold and plans to initiate a new, pivotal Phase 3 study of intrathecal OAV-101 in older patients with SMA

Amy Giles
Increasing Engagement

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

Suma Ramadas, PhD
Medical Affairs

Matt Turner
Patient Affordability

David Linetsky
Patient Activation

Thomas Shea
Programmatic Marketing

Mike Viscel
Increasing Engagement

Liz Kane
Impactful Strategy

Stacey Gandler
Brand Nourishment

Pat Purcell
Meeting Engagement

Laura Blair
Medication Adherence

Matthew Durham
Omnidynamic Marketing

Bud Bilanich
Success Coach

Paul Theisen
Patient Acquisition

Anil Bhaskar
Unified Customer Experience

Brenda Snow
Authentic Patient Voice

Frank X. Powers
Healthcare Challenger Brands